Does INSULIN LISPRO Cause Injection site mass? 266 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 266 reports of Injection site mass have been filed in association with INSULIN LISPRO (Humalog KwikPen). This represents 0.3% of all adverse event reports for INSULIN LISPRO.
266
Reports of Injection site mass with INSULIN LISPRO
0.3%
of all INSULIN LISPRO reports
0
Deaths
23
Hospitalizations
How Dangerous Is Injection site mass From INSULIN LISPRO?
Of the 266 reports, 23 (8.6%) required hospitalization.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN LISPRO. However, 266 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN LISPRO Cause?
Blood glucose increased (31,969)
Incorrect dose administered (8,318)
Blood glucose decreased (6,439)
Drug ineffective (5,411)
Visual impairment (4,654)
Underdose (3,156)
Drug dose omission (3,063)
Glycosylated haemoglobin increased (2,482)
Blood glucose abnormal (2,460)
Malaise (2,204)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
Which INSULIN LISPRO Alternatives Have Lower Injection site mass Risk?
INSULIN LISPRO vs INSULIN LISPRO-AABC
INSULIN LISPRO vs INSULIN NOS
INSULIN LISPRO vs INSULIN PORK\INSULIN PURIFIED PORK
INSULIN LISPRO vs INTERFERON
INSULIN LISPRO vs INTERFERON ALFA-2A